Cure Parkinsons and Van Andel Institute renew funding for Parkinson’s clinical trial programme
Cure Parkinson’s and Van Andel Institute (VAI) have renewed a funding agreement to support the International Linked Clinical Trials (iLCT) programme, the world’s largest drug repurposing clinical trial initiative for Parkinson’s disease. As part of the three-year agreement, VAI and Cure Parkinson’s each pledge $750,000…
Launch of a Global Alliance for Parkinson’s Platforms (GAPP); bringing together international leaders of Parkinson’s platform trials
Stakeholders involved in the setup and running of Parkinson’s platform trials met in November for the second annual International PD-Platform Meeting. The result was the launch of GAPP with representatives from the UK, France, the US, Norway, and Australia. GAPP is facilitated by a collaboration…
Cure Parkinson’s and MS Society deliver workshop to promote collaboration in delivery of clinical trials in neurology
Cure Parkinson’s have partnered with the MS Society to deliver an industry engagement workshop. The aim is to create discussion between academia and the biotech and pharmaceutical industry. This dialogue could identify opportunities and address challenges for collaboration in the use of clinical trial platforms…
Cure Parkinson’s invite applications for interns to join their research committee
Cure Parkinson’s are inviting applications for early-career researchers (ECRs) to join their research grant evaluation committee. The aim of the internships is to provide early career researchers with experience and exposure to a grant review process. Applicants for these positions must be either a PhD…
Walk To Cure Parkinson’s raises over £39,500
Inspired by our late co-founder Tom Isaacs’ 4,500 mile walk around the British coast, we asked our supporters to mark 20 years of the charity with a Walk To Cure Parkinson’s. In 2002, Tom set off on Coastin’: a year-long walk around the coastline of…